Ophthalmic drug delivery device
AssigneeAlcon Inc.
InventorYoseph Yaacobi
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a drug delivery device for a human eye. The human eye has a sclera, an inferior oblique muscle, and a macula. The device of the present invention includes a pharmaceutically active agent, and a geometry that facilitates the implantation of the device on an outer surface of the sclera, beneath the inferior oblique muscle, and with the pharmaceutically active agent disposed above the macula. Methods of delivery a pharmaceutically active agent to the posterior segment of the human eye are also disclosed.
Claims12
A drug delivery device for a human eye, said eye having a sclera, a plurality of extraocular muscles including an inferior oblique muscle, and a macula, said device comprising:
- a pharmaceutically active agent;
- and
- a body having a geometry that facilitates an implantation of said device on an outer surface of said sclera, beneath said inferior oblique muscle, with said pharmaceutically active agent disposed above said macula, and without disinsertion or cutting of any of said plurality of extraocular muscles.
A method of delivering a pharmaceutically active agent to a human eye, said human eye having a sclera, a plurality of extraocular muscles including an inferior oblique muscle, and a macula, comprising the steps of:
- providing a drug delivery device comprising:
- a pharmaceutically active agent;
- and
- a body having a geometry that facilitates an implantation of said device on an outer surface of said sclera, beneath said inferior oblique muscle, with said pharmaceutically active agent disposed above said macula, and without disinsertion or cutting of any of said plurality of extraocular muscles;
- and
- disposing said device on said outer surface of said sclera, beneath said inferior oblique muscle, and with said pharmaceutically active agent disposed above said macula.
Dependencies are inferred from the claim text.